Stephen M Bloch
CIK 1400308 · last filed 2026-07-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$49.22M
Companies
3
Total Filings
80
Lifetime Open-Market Net
-$307.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | Director | 735,665 | $66.91 | $49.22M | -$118.66M | 19 | 2026-07-24 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | 618,479 | $0.55 | $340.2K | $5.00M | 5 | 2016-02-04 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 1,652,390 | $14.49 | $23.94M | -$193.34M | 50 | 2009-02-12 |
Recent Filings · Page 3 of 8
80 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-10 | — | Grant (A) | +319,488 | $1000.0K | |
| 2019-09-03 | — | Grant (A) | — | $0 | |
| 2019-03-04 | — | Exer (X) | +34,378 | $344 | |
| 2018-08-01 | — | Mixed | +2,560,604 | $8.00M | |
| 2018-07-27 | — | Grant (A) | — | $0 | |
| 2016-02-04 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Mixed | +39,550 | $41.1K | EDGAR |
| 2015-09-28 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Mixed | +39,550 | $41.1K | EDGAR |
| 2015-06-11 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Mixed | — | $3.1K | EDGAR |
| 2014-10-02 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-08-06 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Mixed | +2,461,398 | $5.00M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.